Consolidated Statements of Cash Flows (Unaudited) - USD ($)	9 Months Ended
	Sep. 30, 2016	Sep. 30, 2015
Cash flows from operating activities:
Net Income	$ 2,129,931	$ 1,645,040
Adjustments to reconcile net income to net cash provided by operating activities -
Amortization of deferred financing costs	51,474	27,501
Depreciation	2,752	4,926
Non cash compensation expense	10,192	10,248
Loss on write-down of investment in privately held company (Note 5)	10,000	15,000
Changes in operating assets and liabilities:
Interest receivable on loans	78,234	(108,815)
Other current and non current assets	(16,809)	(27,377)
Accounts payable and accrued expenses	(27,702)	(74,031)
Deferred origination fees	64,879	4,360
Net cash provided by operating activities	2,302,951	1,496,852
Cash flows from investing activities:
Issuance of short term loans	(24,299,500)	(15,346,500)
Collections received from loans	23,671,720	10,234,936
Purchase of fixed assets	(3,019)	(3,474)
Net cash used in investing activities	(630,799)	(5,115,038)
Cash flows from financing activities:
(Repayments of) Proceeds from loans and line of credit, net	(8,653,664)	1,024,238
Cash restricted for reduction of line of credit	(919,352)
Proceeds from public offerings, net	9,539,347	4,237,199
Deferred financing costs		(111,400)
Proceeds from exercise of stock options and warrants	305,004	32,838
Dividends paid	(1,891,804)	(1,551,221)
Net cash (used in) provided by financing activities	(1,620,469)	3,631,654
Net increase in cash and cash equivalents	51,683	13,468
Cash and cash equivalents, beginning of period	106,836	47,676
Cash and cash equivalents, end of period	158,519	61,144
Supplemental Cash Flow Information:
Taxes paid during the period	1,948	29
Interest paid during the period	$ 546,015	$ 423,650